<?xml version="1.0" encoding="UTF-8"?>
<p id="Par13">A recent single arm study performed on 20 COVID-19 patients shows that the use of hydroxychloroquine also by adding the antibacterial drug azithromycin is efficient in viral load reduction/disappearance [
 <xref ref-type="bibr" rid="CR16">16</xref>]. Hydroxychloroquine and chloroquine's antiviral activity appears to be due to the increase in endosomal ph which is crucial for virus-cell fusion [
 <xref ref-type="bibr" rid="CR17">17</xref>, 
 <xref ref-type="bibr" rid="CR18">18</xref>]. Azithromycin, in addition to inhibiting the protein synthesis of bacteria, is able to mitigate inflammation and modulate the immune system [
 <xref ref-type="bibr" rid="CR19">19</xref>, 
 <xref ref-type="bibr" rid="CR20">20</xref>].
</p>
